Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124031062 | 12403106 | 2 | F | 20130203 | 20160824 | 20160525 | 20160829 | EXP | DK-DKMA-ADR 23479728 | DK-ROCHE-1760214 | ROCHE | 69.50 | YR | M | Y | 0.00000 | 20160829 | LW | DK | DK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124031062 | 12403106 | 1 | PS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | THE PATIENT ALSO RECEIVED TREATMENT ON 02/NOV/2012, 23/NOV/2012, 14/DEC/2012 AND ON 04/JAN/2013 | U | 103705 | 800 | MG | SOLUTION FOR INFUSION | ||||||
| 124031062 | 12403106 | 2 | SS | ADRIAMYCIN | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | THE PATIENT ALSO RECEIVED TREATMENT ON: 02/NOV/2012, 23/NOV/2012, 14/DEC/2012 AND ON 04/JAN/2013 | U | 0 | 100 | MG | |||||||
| 124031062 | 12403106 | 3 | SS | ONCOVIN | VINCRISTINE SULFATE | 1 | Intravenous (not otherwise specified) | FORM STRENGTH: 1 MG/ML?THE PATIENT ALSO RECEIVED TREATMENT ON 02/NOV/2012, 23/NOV/2012, 14/DEC/2012 | U | 0 | 2 | MG | SOLUTION FOR INJECTION | ||||||
| 124031062 | 12403106 | 4 | SS | SENDOXAN | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | THE PATIENT ALSO RECEIVED TREATMENT ON 02/NOV/2012, 23/NOV/2012, 14/DEC/2012 AND ON 04/JAN/2013 | U | 0 | 1500 | MG | |||||||
| 124031062 | 12403106 | 5 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | 02/NOV/2012, 23/NOV/2012, 14/DEC/2012 AND ON 04/JAN/2013 | 0 | ||||||||||
| 124031062 | 12403106 | 6 | C | VICTOZA | LIRAGLUTIDE | 1 | Unknown | 0 | |||||||||||
| 124031062 | 12403106 | 7 | C | MAREVAN | WARFARIN SODIUM | 1 | Unknown | 10 PCS PER 1 WEEK | 0 | ||||||||||
| 124031062 | 12403106 | 8 | C | DICLON | DICLOFENAC SODIUM | 1 | Unknown | 0 | QD | ||||||||||
| 124031062 | 12403106 | 9 | C | PINEX (DENMARK) | 2 | Unknown | 0 | 500 | MG | ||||||||||
| 124031062 | 12403106 | 10 | C | HJERTEMAGNYL | ASPIRINMAGNESIUM OXIDE | 1 | Unknown | 0 | QD | ||||||||||
| 124031062 | 12403106 | 11 | C | ACYCLOVIR. | ACYCLOVIR | 1 | Unknown | UNKNOWN DOSE | 0 | ||||||||||
| 124031062 | 12403106 | 12 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | 0 | QD | ||||||||||
| 124031062 | 12403106 | 13 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | Unknown | 0 | QD | ||||||||||
| 124031062 | 12403106 | 14 | C | CODEINE | CODEINE | 1 | Unknown | 0 | QID | ||||||||||
| 124031062 | 12403106 | 15 | C | IBUPROFEN. | IBUPROFEN | 1 | Unknown | 0 | TID | ||||||||||
| 124031062 | 12403106 | 16 | C | METOPROLOL SUCCINATE. | METOPROLOL SUCCINATE | 1 | Unknown | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124031062 | 12403106 | 1 | Lymphoma |
| 124031062 | 12403106 | 2 | Lymphoma |
| 124031062 | 12403106 | 3 | Lymphoma |
| 124031062 | 12403106 | 4 | Lymphoma |
| 124031062 | 12403106 | 5 | Lymphoma |
| 124031062 | 12403106 | 6 | Product used for unknown indication |
| 124031062 | 12403106 | 7 | Product used for unknown indication |
| 124031062 | 12403106 | 8 | Product used for unknown indication |
| 124031062 | 12403106 | 9 | Product used for unknown indication |
| 124031062 | 12403106 | 10 | Product used for unknown indication |
| 124031062 | 12403106 | 11 | Product used for unknown indication |
| 124031062 | 12403106 | 12 | Product used for unknown indication |
| 124031062 | 12403106 | 13 | Product used for unknown indication |
| 124031062 | 12403106 | 14 | Product used for unknown indication |
| 124031062 | 12403106 | 15 | Product used for unknown indication |
| 124031062 | 12403106 | 16 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124031062 | 12403106 | HO |
| 124031062 | 12403106 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124031062 | 12403106 | Abdominal cavity drainage | |
| 124031062 | 12403106 | Ascites | |
| 124031062 | 12403106 | Asthenia | |
| 124031062 | 12403106 | Cardiac failure | |
| 124031062 | 12403106 | Cardiac pacemaker insertion | |
| 124031062 | 12403106 | Cardiomegaly | |
| 124031062 | 12403106 | Dyspnoea | |
| 124031062 | 12403106 | Ejection fraction decreased | |
| 124031062 | 12403106 | Fatigue | |
| 124031062 | 12403106 | Feeling of body temperature change | |
| 124031062 | 12403106 | Oedema peripheral | |
| 124031062 | 12403106 | Pleural effusion | |
| 124031062 | 12403106 | Pneumonia | |
| 124031062 | 12403106 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124031062 | 12403106 | 1 | 20121012 | 20130429 | 0 | |
| 124031062 | 12403106 | 2 | 20121012 | 20130125 | 0 | |
| 124031062 | 12403106 | 3 | 20121012 | 20130125 | 0 | |
| 124031062 | 12403106 | 4 | 20121012 | 20130125 | 0 | |
| 124031062 | 12403106 | 5 | 20121012 | 20130125 | 0 |